Cargando…

Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer

Detalles Bibliográficos
Autores principales: Nair, Nitya, Lemmens, Ed, Enstrom, Amanda, Chen, Shih-Yu, Chang, Serena, Le, Dung, Jaffee, Elizabeth M, Maecker, Holden, Murphy, Aimee L, Brockstedt, Dirk G, Whiting, Chan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646101/
http://dx.doi.org/10.1186/2051-1426-3-S2-P102
_version_ 1782400914623037440
author Nair, Nitya
Lemmens, Ed
Enstrom, Amanda
Chen, Shih-Yu
Chang, Serena
Le, Dung
Jaffee, Elizabeth M
Maecker, Holden
Murphy, Aimee L
Brockstedt, Dirk G
Whiting, Chan
author_facet Nair, Nitya
Lemmens, Ed
Enstrom, Amanda
Chen, Shih-Yu
Chang, Serena
Le, Dung
Jaffee, Elizabeth M
Maecker, Holden
Murphy, Aimee L
Brockstedt, Dirk G
Whiting, Chan
author_sort Nair, Nitya
collection PubMed
description
format Online
Article
Text
id pubmed-4646101
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46461012015-11-20 Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer Nair, Nitya Lemmens, Ed Enstrom, Amanda Chen, Shih-Yu Chang, Serena Le, Dung Jaffee, Elizabeth M Maecker, Holden Murphy, Aimee L Brockstedt, Dirk G Whiting, Chan J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4646101/ http://dx.doi.org/10.1186/2051-1426-3-S2-P102 Text en Copyright © 2015 Nair et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Nair, Nitya
Lemmens, Ed
Enstrom, Amanda
Chen, Shih-Yu
Chang, Serena
Le, Dung
Jaffee, Elizabeth M
Maecker, Holden
Murphy, Aimee L
Brockstedt, Dirk G
Whiting, Chan
Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer
title Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer
title_full Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer
title_fullStr Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer
title_full_unstemmed Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer
title_short Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer
title_sort long term survivors and immune biomarker analysis of phase iia, randomized study of gvax pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646101/
http://dx.doi.org/10.1186/2051-1426-3-S2-P102
work_keys_str_mv AT nairnitya longtermsurvivorsandimmunebiomarkeranalysisofphaseiiarandomizedstudyofgvaxpancreasandcrs207immunotherapyinpatientswithmetastaticpancreaticcancer
AT lemmensed longtermsurvivorsandimmunebiomarkeranalysisofphaseiiarandomizedstudyofgvaxpancreasandcrs207immunotherapyinpatientswithmetastaticpancreaticcancer
AT enstromamanda longtermsurvivorsandimmunebiomarkeranalysisofphaseiiarandomizedstudyofgvaxpancreasandcrs207immunotherapyinpatientswithmetastaticpancreaticcancer
AT chenshihyu longtermsurvivorsandimmunebiomarkeranalysisofphaseiiarandomizedstudyofgvaxpancreasandcrs207immunotherapyinpatientswithmetastaticpancreaticcancer
AT changserena longtermsurvivorsandimmunebiomarkeranalysisofphaseiiarandomizedstudyofgvaxpancreasandcrs207immunotherapyinpatientswithmetastaticpancreaticcancer
AT ledung longtermsurvivorsandimmunebiomarkeranalysisofphaseiiarandomizedstudyofgvaxpancreasandcrs207immunotherapyinpatientswithmetastaticpancreaticcancer
AT jaffeeelizabethm longtermsurvivorsandimmunebiomarkeranalysisofphaseiiarandomizedstudyofgvaxpancreasandcrs207immunotherapyinpatientswithmetastaticpancreaticcancer
AT maeckerholden longtermsurvivorsandimmunebiomarkeranalysisofphaseiiarandomizedstudyofgvaxpancreasandcrs207immunotherapyinpatientswithmetastaticpancreaticcancer
AT murphyaimeel longtermsurvivorsandimmunebiomarkeranalysisofphaseiiarandomizedstudyofgvaxpancreasandcrs207immunotherapyinpatientswithmetastaticpancreaticcancer
AT brockstedtdirkg longtermsurvivorsandimmunebiomarkeranalysisofphaseiiarandomizedstudyofgvaxpancreasandcrs207immunotherapyinpatientswithmetastaticpancreaticcancer
AT whitingchan longtermsurvivorsandimmunebiomarkeranalysisofphaseiiarandomizedstudyofgvaxpancreasandcrs207immunotherapyinpatientswithmetastaticpancreaticcancer